"It has to be given at an early stage and is a potential game changer as it can be given in tablet form and thus is easy to administer, and is relatively inexpensive," he said. 4) Glenmark is ...

Specifically, Glenmark’s own probe into rejected batches “failed to extend to other batches, dosage strengths and drug products for tablet compression machine settings,” the FDA said.

BENGALURU (Reuters) - Glenmark Pharmaceuticals Ltd said on Monday it would lower the price of its generic version of favipiravir, FabiFlu, to 75 rupees ($0.9983) per tablet for restricted ...

of Rs 3,500 for a strip of 34 tablets, Glenmark Pharmaceuticals said. Drug firm Glenmark Pharmaceuticals on Saturday said it has launched antiviral drug Favipiravir, under the brand name FabiFlu ...

Glenmark Pharmaceuticals Ltd. (Glenmark), an innovation-driven, global pharmaceutical company, launched the sacubitril + valsartan tablets in India, for the treatment of heart failure. Marketed under ...

Glenmark Pharmaceuticals Ltd. (Glenmark) has received final approval by the United States Food & Drug Administration (U.S. FDA) for Fluphenazine Hydrochloride Tablets USP, 1 mg, 2.5 mg, 5 mg, and ...

Glenmark had previously announced that the United States Food and Drug Administration (USFDA) had tentatively approved their generic Axitinib Tablets, 1 mg, and 5 mg, for release on November 30 ...

BENGALURU (Reuters) - Glenmark Pharmaceuticals Ltd said on Monday it would lower the price of its generic version of favipiravir, FabiFlu, to 75 rupees ($0.9983) per tablet for restricted ...

BENGALURU, July 13 (Reuters) - Glenmark Pharmaceuticals Ltd GLEN.NS said on Monday it would lower the price of its generic version of favipiravir, FabiFlu, to 75 rupees ($0.9983) per tablet for ...